# eyonis LCS

Type: Product

Source: AI Intelligence Brief — https://getaibrief.com/entity/eyonis-lcs
Canonical HTML page: https://getaibrief.com/entity/eyonis-lcs

## Recent coverage (1 stories)

### FDA Clears First AI Model for Lung Cancer Malignancy Risk, 75% Accuracy Gain
2026-08-04 01:06:43 · Sentiment: Positive · Impact: 6/10 · Sources: 2

eyonis LCS becomes the first FDA-cleared AI Software as a Medical Device to assess lung nodule malignancy, and its commercial partnership with Canon’s Olea Medical validates the scale-up of AI diagnostics in radiology.
Full story: https://getaibrief.com/story/fda-clears-ai-eyonis-lcs-lung-cancer-screening

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getaibrief.com/guides/methodology for the full editorial methodology.